These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 16344319)
1. High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma. Abdel-Rahman MH; Yang Y; Zhou XP; Craig EL; Davidorf FH; Eng C J Clin Oncol; 2006 Jan; 24(2):288-95. PubMed ID: 16344319 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation. Zhou XP; Gimm O; Hampel H; Niemann T; Walker MJ; Eng C Am J Pathol; 2000 Oct; 157(4):1123-8. PubMed ID: 11021816 [TBL] [Abstract][Full Text] [Related]
3. Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma. Merbs SL; Sidransky D Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):779-83. PubMed ID: 10067984 [TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity of 1p in uveal melanomas with monosomy 3. Häusler T; Stang A; Anastassiou G; Jöckel KH; Mrzyk S; Horsthemke B; Lohmann DR; Zeschnigk M Int J Cancer; 2005 Oct; 116(6):909-13. PubMed ID: 15849744 [TBL] [Abstract][Full Text] [Related]
5. Frequency, molecular pathology and potential clinical significance of partial chromosome 3 aberrations in uveal melanoma. Abdel-Rahman MH; Christopher BN; Faramawi MF; Said-Ahmed K; Cole C; McFaddin A; Ray-Chaudhury A; Heerema N; Davidorf FH Mod Pathol; 2011 Jul; 24(7):954-62. PubMed ID: 21499235 [TBL] [Abstract][Full Text] [Related]
6. [Research on the mechanisms of PTEN gene inactivation in ovarian cancer]. Lü QJ; Zhao XD; Song JY; Li XH; Ma Y; Meng H; Jiang WG Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):266-9. PubMed ID: 16181546 [TBL] [Abstract][Full Text] [Related]
7. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052 [TBL] [Abstract][Full Text] [Related]
8. Mutations of the KIT gene and loss of heterozygosity of the PTEN region in a primary malignant melanoma arising from a mature cystic teratoma of the ovary. Tate G; Tajiri T; Suzuki T; Mitsuya T Cancer Genet Cytogenet; 2009 Apr; 190(1):15-20. PubMed ID: 19264228 [TBL] [Abstract][Full Text] [Related]
9. PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines. Pollock PM; Walker GJ; Glendening JM; Que Noy T; Bloch NC; Fountain JW; Hayward NK Melanoma Res; 2002 Dec; 12(6):565-75. PubMed ID: 12459646 [TBL] [Abstract][Full Text] [Related]
10. Status of the NF1 tumor suppressor locus in uveal melanoma. Foster WJ; Fuller CE; Perry A; Harbour JW Arch Ophthalmol; 2003 Sep; 121(9):1311-5. PubMed ID: 12963615 [TBL] [Abstract][Full Text] [Related]
11. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859 [TBL] [Abstract][Full Text] [Related]
12. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387 [TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity of the thyroid hormone receptor B in posterior uveal melanoma. Sisley K; Curtis D; Rennie IG; Rees RC Melanoma Res; 1993 Dec; 3(6):457-61. PubMed ID: 7909244 [TBL] [Abstract][Full Text] [Related]
14. Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome. Mensink HW; Kiliç E; Vaarwater J; Douben H; Paridaens D; de Klein A Cancer Genet Cytogenet; 2008 Mar; 181(2):108-11. PubMed ID: 18295662 [TBL] [Abstract][Full Text] [Related]
15. Clinical and cytogenetic analyses in uveal melanoma. Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076 [TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma. Edmunds SC; Kelsell DP; Hungerford JL; Cree IA Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501 [TBL] [Abstract][Full Text] [Related]
17. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma. Ohta M; Berd D; Shimizu M; Nagai H; Cotticelli M-G ; Mastrangelo M; Shields JA; Shields CL; Croce CM; Huebner K Int J Cancer; 1996 Mar; 65(6):762-7. PubMed ID: 8631588 [TBL] [Abstract][Full Text] [Related]
18. Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization. Speicher MR; Prescher G; du Manoir S; Jauch A; Horsthemke B; Bornfeld N; Becher R; Cremer T Cancer Res; 1994 Jul; 54(14):3817-23. PubMed ID: 8033101 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma. Maat W; Beiboer SH; Jager MJ; Luyten GP; Gruis NA; van der Velden PA Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1291-8. PubMed ID: 18385040 [TBL] [Abstract][Full Text] [Related]
20. Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma. Cross NA; Ganesh A; Parpia M; Murray AK; Rennie IG; Sisley K Eye (Lond); 2006 Apr; 20(4):476-81. PubMed ID: 15920570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]